The results for efficacy and safety over the time course of the VEGF Trap ( aflibercept ) with irinotecan in colorectal cancer after failure of oxaliplatin regimen trial were analysed based on data from @ patients randomised to receive FOLFIRI plus either aflibercept ( n = @ ) or placebo ( n = @ ) .